- pause slideshow
Cuts to public health budgets have been six times larger in the UK’s most deprived areas compared with cuts made in the country’s least deprived areas, a report has found.
The National Institute for Health and Care Excellence has recommended two cannabis-based medicinal products for reimbursement under the NHS.
The General Pharmaceutical Council has asked pharmacists to “consider the limitations” of providing services online when deciding on the scope of practice they can provide.
Reports of lost, stolen or missing controlled drugs in England increased by 19% between 2017/2018 and 2018/2019.
A Labour Party government would bring hospital pharmacies run by private companies back into NHS ownership, a party spokesperson has said.
Using an oral spray to deliver vitamin D is just as effective as a capsule, research published in the European Journal of Clinical Nutrition has shown.
Decision aids could help GPs and patients in the process of discontinuing antidepressants, researchers have said.
Oral antibiotic use is linked to an increased risk of colon cancer, but a reduced risk of rectal cancer, a study in Gut suggests.
Patients exposed to fluoroquinolone antibiotics are more than twice as likely to develop aortic or mitral regurgitation, compared with patients taking amoxicillin, according to research published in the Journal of the American College of Cardiology.
Patients treated with nivolumab for advanced non-small cell lung carcinoma had a better survival rate at five years than those who received chemotherapy, a follow-up trial has shown.
With almost 1,400 reports of controlled drugs being lost, stolen or missing in the past year, there are concerns regarding the increasing sophistication of those trying to subvert the system.
One year since UK law changed to enable medical cannabis to be prescribed, researchers are exploring the drug’s potential for treating post-traumatic stress disorder, schizophrenia and attention deficit hyperactivity disorder.
As the prevalence of sexually transmitted infections continues to rise and sexual health services remain under financial strain, pharmacists are increasingly being called upon to do more to bridge the gap.
The government’s latest scheme to tackle thinly stretched NHS services is set to launch on 29 October 2019, and it places community pharmacy at its core.
Is hormone replacement therapy worth the risks?Subscription
The risks and benefits of hormone replacement therapy (HRT) have long been the source of confusion and controversy. Here we summarise the latest evidence to assist pharmacists in supporting patients thinking about HRT.